EATON VANCE MANAGEMENT - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
EATON VANCE MANAGEMENT ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,561,000
-5.3%
237,1550.0%0.00%0.0%
Q2 2022$2,704,000
+25.2%
237,1550.0%0.00%
+100.0%
Q1 2022$2,160,000
-38.9%
237,1550.0%0.00%
-50.0%
Q4 2021$3,538,000
-42.0%
237,1550.0%0.00%
-50.0%
Q3 2021$6,095,000
-1.5%
237,1550.0%0.01%0.0%
Q2 2021$6,185,000
-26.2%
237,155
-0.1%
0.01%
-33.3%
Q1 2021$8,379,000
-30.0%
237,353
-50.0%
0.01%
+33.3%
Q4 2020$11,972,000
+33.9%
474,310
+100.0%
0.01%
-43.8%
Q3 2020$8,943,000
-11.9%
237,1550.0%0.02%
-23.8%
Q2 2020$10,155,000
+120.3%
237,1550.0%0.02%
+90.9%
Q1 2020$4,610,000237,1550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders